Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 23.1T | 24.8T | 23.9T | 23.8T |
Cost of revenue | 21.1T | 22.7T | 21.6T | 21.5T |
Gross profit | 2.0T | 2.1T | 2.3T | 2.3T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 753.2B | 752.0B | 1.0T | 850.7B |
Other operating expenses | 230.3B | 233.9B | 240.4B | 120.5B |
Operating income | 305.7B | 36.1B | 260.3B | 611.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 120.3B | 61.5B | 78.6B | 172.1B |
Other income expense | — | — | — | — |
Pretax income | 195.1B | 23.2B | 126.5B | 459.7B |
Tax provision | 87.6B | 34.6B | 59.8B | 129.7B |
Net income | 107.5B | -11.4B | 66.7B | 329.9B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 528.9B | 309.9B | 423.4B | 848.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -3.1B | 0 | 2M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |